Elisabeth Leiderman
Director/Board Member bij BLUEBIRD BIO, INC.
Vermogen: 28 488 $ op 31-03-2024
Actieve functies van Elisabeth Leiderman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| BLUEBIRD BIO, INC. | Director/Board Member | 15-10-2021 | - |
| Independent Dir/Board Member | 15-10-2021 | - | |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 20-12-2023 | - |
Loopbaan van Elisabeth Leiderman
Eerdere bekende functies van Elisabeth Leiderman
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Atsena Therapeutics, Inc.
 Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Director of Finance/CFO | 07-11-2022 | 01-11-2023 |
| DECIBEL THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 09-09-2021 | 07-10-2022 |
| Director of Finance/CFO | 01-09-2020 | 07-10-2022 | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Corporate Officer/Principal | 01-11-2016 | 01-08-2020 |
| Nomura Securities, Inc. | Director/Board Member | 01-01-2013 | 01-07-2016 |
| FORTRESS BIOTECH, INC. | Corporate Officer/Principal | 01-01-2007 | 01-01-2016 |
Opleiding van Elisabeth Leiderman
| University of Pennsylvania | Undergraduate Degree |
| The Wharton School of the University of Pennsylvania | Masters Business Admin |
| Sackler School of Medicine | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 9 |
| Israël | 2 |
| Verenigd Koninkrijk | 2 |
Operationeel
| Director/Board Member | 3 |
| Corporate Officer/Principal | 2 |
| Director of Finance/CFO | 2 |
Sectoraal
| Health Technology | 7 |
| Consumer Services | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| FORTRESS BIOTECH, INC. | Health Technology |
| BLUEBIRD BIO, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Complexa, Inc.
Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
Atsena Therapeutics, Inc.
Atsena Therapeutics, Inc. BiotechnologyHealth Technology Atsena Therapeutics, Inc. engages in biotechnology business. The company is headquartered in Durham, NC. | Health Technology |
| Nomura Securities, Inc. |
- Beurs
- Insiders
- Elisabeth Leiderman
- Ervaring
